|
|
| (15 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|R}} |
| | + | |
| | + | how to work in a hygienic medical environment. |
| | + | |
| | *'''[[RUN Anesthesia]]''' | | *'''[[RUN Anesthesia]]''' |
| | *'''[[RUN Transplantation]]''' | | *'''[[RUN Transplantation]]''' |
| Zeile 14: |
Zeile 18: |
| | *'''[[RUN Diabetes]]''' | | *'''[[RUN Diabetes]]''' |
| | *'''[[RUN Gastroenterology]]''' | | *'''[[RUN Gastroenterology]]''' |
| | + | *'''[[RUN Hematology]]''' |
| | *'''[[RUN Oncology]]''' | | *'''[[RUN Oncology]]''' |
| | *'''[[RUN Sugery]]''' | | *'''[[RUN Sugery]]''' |
| Zeile 31: |
Zeile 36: |
| | *'''[[RUN Emergency medicine]]''' | | *'''[[RUN Emergency medicine]]''' |
| | *'''[[RUN Hygiene, hosp.gen.]]''' | | *'''[[RUN Hygiene, hosp.gen.]]''' |
| − | *'''[[RUN Nuring Homes]]''' | + | *'''[[RUN Nursing Homes, Palliative Med.]]''' |
| − | | + | *'''[[RUN Rehab, Physio, Chiro]]''' |
| − | | + | *'''[[RUN Pathology, Forensic, Laboratory]]''' |
| − | | + | |
| − | *'''[[RUN ]]''' | + | |
| − | *'''[[RUN ]]''' | + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | *'''[[RUN ]]'''
| + | |
| − | | + | |
| | *'''[[EDU stalled research]]''' | | *'''[[EDU stalled research]]''' |
| | *'''[[EDU stalled edu cme]]''' | | *'''[[EDU stalled edu cme]]''' |
| | *'''[[EDU journals]]''' | | *'''[[EDU journals]]''' |
| − | *'''[[EDU ]]''' | + | *'''[[RRR Restauration]]''' |
| − | *'''[[EDU ]]'''
| + | |
| − | *'''[[EDU ]]'''
| + | |
| − | | + | |
| | | | |
| | | | |
| Zeile 101: |
Zeile 91: |
| | {{tp|p=32377597|t=ä. Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic |pdf=|usr=}} | | {{tp|p=32377597|t=ä. Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic |pdf=|usr=}} |
| | {{tp|p=32277351|t=ä. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic |pdf=|usr=}} | | {{tp|p=32277351|t=ä. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic |pdf=|usr=}} |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32268390|t=2020. Responding to COVID-19: The UW Medicine Information Technology Services Experience |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32309812|t=2020. Prone Position in Management of COVID-19 Patients; a Commentary |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | '''Blood component mgmt'''
| |
| − | {{tp|p=32243296|t=2020. Essential Role of Patient Blood Management in a Pandemic: A Call for Action |pdf=|usr=}}
| |
| − | {{tp|p=32267830|t=2020. Blood transfusion during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32267829|t=2020. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | '''Psychiatry (on general population)'''
| |
| − |
| |
| − |
| |
| − | '''Rehab'''
| |
| − | {{tp|p=32194034|t=ä. How Should the Rehabilitation Community Prepare for 2019-nCoV?|pdf=|usr=}}
| |
| − |
| |
| − | '''Laboratory medicine'''
| |
| − | {{tp|p=32190890|t=2020. Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32283513|t=2020. Psychiatrist in post-COVID-19 era ? Are we prepared?|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32251716|t=ä. What is the role of rheumatologists in the era of COVID-19?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32265184|t=2020. Ready for a long fight against the COVID-19 outbreak: an innovative model of tiered primary health care in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32345692|t=2020. Paying SPECIAL consideration to the digital sharing of information during the COVID-19 pandemic and beyond |pdf=|usr=}}
| |
| − | {{tp|p=32345693|t=2020. Enhancing the triage and cohort of patients in public primary care clinics in response to the coronavirus disease 2019 (COVID-19) in Hong Kong: an experience from a hospital cluster |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32267768|t=2020. COVID-19 and emergency planning |pdf=|usr=}}
| |
| − | {{tp|p=32267769|t=2020. Legal aspects of COVID-19 pandemic management for community nurses |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32279545|t=2020. The consequences of COVID-19 for gastroenterology nursing |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32312585|t=ä. Reducing medical error during a pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32335078|t=ä. Deep Impact of COVID-19 in the HealthCare of Latin America: the case of Brazil |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32333290|t=ä. The piecework anesthetists solution to the lack of ventilators during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32344000|t=ä. COVID-19: A Time for Alternate Models in Cardiac Rehabilitation to Take Center Stage |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32302561|t=2020. COVID-19: Navigating Uncertainties Together |pdf=|usr=}}
| |
| − | {{tp|p=32339510|t=ä. Regional Planning for Extracorporeal Membrane Oxygenation Allocation During Coronavirus Disease 2019 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32289312|t=ä. Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | güllül
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32166310|t=ä. A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2) |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32330569|t=ä. Clinical microbiology laboratory adaptation to COVID-19 emergency: experience at a large teaching hospital in Rome, Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32299617|t=2020. Respirators and surgical facemasks for COVID-19: implications for MRI |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32152059|t=2020. Proposed protocol to keep COVID-19 out of hospitals |pdf=|usr=}}
| |
| − | {{tp|p=32269020|t=2020. Projecting demand for critical care beds during COVID-19 outbreaks in Canada |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32336679|t=2020. Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32183864|t=2020. Safe patient transport for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32070391|t=2020. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32345337|t=2020. Is a more aggressive COVID-19 case detection approach mitigating the burden on ICUs? Some reflections from Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32321566|t=2020. Managing COVID-19 in resource-limited settings: critical care considerations |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32321562|t=2020. Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32172175|t=2020. Clinical considerations for patients with diabetes in times of COVID-19 epidemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32305399|t=ä. COVID-19 and diabetes management: What should be considered?|pdf=|usr=}}
| |
| − | {{tp|p=32351631|t=ä. The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32317038|t=ä. Coronavirus Disease 2019 Pandemic: Health System and Community Response to a Text Message (Text4Hope) Program Supporting Mental Health in Alberta |pdf=|usr=}}
| |
| − | {{tp|p=32295659|t=ä. Drawing on Israel?s Experience Organizing Volunteers to Operationalize Drive-Through Coronavirus Testing Centers |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32236913|t=2020. Rechtsfragen der Ressourcenzuteilung in der COVID-19-Pandemie - Zwischen Utilitarismus und Lebenswertindifferenz |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32360075|t=ä. COVID-19 admissions calculators - revisited |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32374801|t=ä. Fair allocation of scarce medical resources during COVID-19 pandemic: ethical considerations |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | üüüüüüüüüüüüüü
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32303841|t=ä. Lead the way or leave the way: leading a Department of Orthopedics through the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32225137|t=2020. Facing in real time the challenges of the Covid-19 epidemic for rehabilitation |pdf=|usr=}}
| |
| − | {{tp|p=32175719|t=2020. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine (PRM) physicians activities in Italy An official document of the Italian PRM Society (SIMFER) |pdf=|usr=}}
| |
| − | {{tp|p=32327266|t=ä. Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?|pdf=|usr=}}
| |
| − | {{tp|p=32264667|t=2020. First impact on services and their preparation "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32329592|t=2020. Organization of acute patients transfer to rehabilitation services during COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32329590|t=2020. Impact of coronavirus disease 2019 (covid-19) outbreak on rehabilitation services and physical medicine and rehabilitation (PM&R) physicians activities: perspectives from the Spanish experience |pdf=|usr=}}
| |
| − | {{tp|p=32329591|t=2020. Covid-19 and child disabilities: whom to protect and how |pdf=|usr=}}
| |
| − | {{tp|p=32293816|t=2020. The impact of covid-19 on rehabilitation services and activities Letter to the editor in response to official document of SIMFER |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32349932|t=ä. Surgical Volume, Safety, Drug Administration, and Clinical Trials During COVID-19: Single-center Experience in Shanghai, China |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32372754|t=2020. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32265003|t=2020. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32198988|t=2020. Safety protection of forensic examination during the epidemic of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32198989|t=2020. Protection of forensic scene investigation and postmortem examination during the epidemic period of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32267530|t=2020. COVID-19 and Family Doctors |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32247755|t=ä. COVID-19 pandemic through the lens of a gastroenterology fellow: looking for the silver lining |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32368710|t=2020. Responding to Healthcare Disparities and Challenges With Access to Care During COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32355634|t=ä. Health policy and technology challenges in responding to the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32196387|t=2020. Strategies to Inform Allocation of Stockpiled Ventilators to Healthcare Facilities During a Pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=C7196380|t=ä. Emergency Medical Services resource capacity and competency amid COVID-19 in the United States: Preliminary findings from a national survey |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32272473|t=2020. Pediatric Endocrinology in the Time of the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32313406|t=ä. COVID 19 Outbreak: Potential of Biochemistry Speciality |pdf=|usr=}}
| |
| − | {{tp|p=32362646|t=2020. Strategic planning to augment the testing capacity for COVID-19 in India |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32242878|t=2020. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32242875|t=2020. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32248880|t=ä. Management-supportive measures for managers of healthcare organizations during the COVID-19 epidemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32290883|t=ä. Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program?s prospective review |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32240484|t=ä. Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China |pdf=|usr=}}
| |
| − | {{tp|p=32222911|t=ä. Providing pharmacy services during the coronavirus pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32370275|t=2020. Preparedness of Frontline Doctors in Jordan Healthcare Facilities to COVID-19 Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32182811|t=2020. Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China) |pdf=|usr=}}
| |
| − | {{tp|p=32230995|t=2020. Quarantine Vehicle Scheduling for Transferring High-Risk Individuals in Epidemic Areas |pdf=|usr=}}
| |
| − | {{tp|p=32225019|t=2020. Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China?s Prevention and Control Strategy for the COVID-19 Epidemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32292636|t=2020. Contingency management strategies of the Nursing Department in centralized rescue of patients with coronavirus disease 2019? |pdf=|usr=}}
| |
| − | {{tp|p=C7129371|t=ä. Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019? |pdf=|usr=}}
| |
| − | {{tp|p=C7128134|t=ä. Emergency management of nursing human resources and supplies to respond to coronavirus disease 2019 epidemic? |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32313713|t=ä. Optimization of the intravenous infusion workflow in the isolation ward for patients with coronavirus disease 2019? |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32083728|t=2020. Global challenges in health and health care for nurses and midwives everywhere |pdf=|usr=}}
| |
| − | {{tp|p=32293554|t=ä. Just when I thought I was out, they pull me back in: the older physician in the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32280052|t=2020. End-of-life decisions and care in the midst of a global coronavirus (COVID-19) pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32304834|t=ä. Risk Communication During COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32287086|t=2020. Practice Management During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32282442|t=2020. A Bioethical Perspective for Navigating Moral Dilemmas Amidst the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32208138|t=ä. Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32229297|t=ä. Lessons Learned During the COVID-19 Virus Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32278730|t=ä. Ongoing Lessons During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32278728|t=ä. Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32278725|t=ä. Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32276721|t=2020. Ethical practice during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32208481|t=ä. Rapid Response to COVID-19: Health Informatics Support for Outbreak Management in an Academic Health System |pdf=|usr=}}
| |
| − | {{tp|p=32348469|t=ä. Laboratory information system requirements to manage the COVID-19 pandemic: a report from the Belgian national reference testing center |pdf=|usr=}}
| |
| − | {{tp|p=32267928|t=ä. Rapid Design and Implementation of an Integrated Patient Self-Triage and Self-Scheduling Tool for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32333757|t=ä. When Past Isn?t a Prologue: Adapting Informatics Practice During a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32336673|t=ä. Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32305209|t=ä. Preparing pharmacy for the surge of patients with COVID-19: Lessons from China |pdf=|usr=}}
| |
| − | {{tp|p=32284276|t=ä. The COVID-19 pandemic: implications for the cytology laboratory |pdf=|usr=}}
| |
| − | {{tp|p=32345566|t=ä. Economic Recovery After the COVID-19 Pandemic: Resuming Elective Orthopedic Surgery and Total Joint Arthroplasty |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32340829|t=ä. Educating Surgeons to Educate Patients About the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32232480|t=2020. Our Response to COVID-19 as Endocrinologists and Diabetologists |pdf=|usr=}}
| |
| − | {{tp|p=32343810|t=ä. Letter to the Editor: Our Response to COVID-19 as Endocrinologists and Diabetologists |pdf=|usr=}}
| |
| − | {{tp|p=32315031|t=ä. Letter to the Editor: ?Our Response to COVID-19 as Endocrinologists and Diabetologists? |pdf=|usr=}}
| |
| − | {{tp|p=32310275|t=ä. Letter to the Editor: ?Our Response to COVID-19 as Endocrinologists and Diabetologists? |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32367999|t=ä. Post COVID-19: Planning strategies to resume orthopaedic surgery ?challenges and considerations |pdf=|usr=}}
| |
| − | {{tp|p=32292256|t=2020. Working through the COVID-19 outbreak: Rapid review and recommendations for MSK and allied heath personnel |pdf=|usr=}}
| |
| − | {{tp|p=32312717|t=2020. Cytology in the time of coronavirus disease (covid-19): an Italian perspective |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32363005|t=ä. COVID-19 and its implications in the management of resource infrastructure |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32340737|t=ä. Can You Catch It? Lessons Learned and Modification of ED Triage Symptom- and Travel-Screening Strategy |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32335855|t=ä. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32246144|t=ä. The Impact of the COVID-19 Pandemic on Disabled and Hospice Home Care Patients |pdf=|usr=}}
| |
| − | {{tp|p=32314784|t=ä. A Frail Health Care System for an Old Population: Lesson form the COVID-19 Outbreak in Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32151674|t=ä. Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer |pdf=|usr=}}
| |
| − | {{tp|p=32259547|t=ä. COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32376717|t=2020. Best interests versus resource allocation: could COVID-19 cloud decision-making for the cognitively impaired?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32220574|t=ä. Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32305270|t=ä. How to prevent outbreak of a hospital-affiliated dementia day-care facility in the pandemic COVID-19 infection in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32303483|t=ä. COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored |pdf=|usr=}}
| |
| − | {{tp|p=32303480|t=ä. Recommendations for protecting against and mitigating the COVID-19 pandemic in long-term care facilities |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32200489|t=ä. Hospitals as health factories and the coronavirus epidemic |pdf=|usr=}}}
| |
| − | {{tp|p=32221059|t=2020. Reflections on Nursing Ingenuity During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − | {{ttp|p=32346683|t=ä. Prevention of COVID-19 in Older Adults: A Brief Guidance from the International Association for Gerontology and Geriatrics (IAGG) Asia/Oceania Region |pdf=|usr=}}
| |
| − | {{ttp|p=32346682|t=ä. The New Challenge of Geriatrics: Saving Frail Older People from the SARS-CoV-2 Pandemic Infection |pdf=|usr=}}
| |
| − | {{tp|p=32346680|t=ä. A COVID-19 Support Platform for Long Term Care Facilities |pdf=|usr=}}
| |
| − | {{tp|p=32346679|t=ä. Geriatric Medicine in Italy in the Time of Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32242202|t=ä. COVID-19 and Older Adult |pdf=|usr=}}
| |
| − | {{tp|p=32346677|t=ä. COVID-19 Spiraling of Frailty in Older Italian Patients |pdf=|usr=}}
| |
| − | {{tp|p=32294453|t=ä. (ObGyn) Current Resources for Evidence-Based Practice, May 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32289259|t=ä. (ObGyn) Reflections on COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32302531|t=ä. The Financial Impact of COVID-19 on Our Practice |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32240755|t=ä. Home Care for Cancer Patients During COVID-19 Pandemic: The Double Triage Protocol |pdf=|usr=}}
| |
| − | {{tp|p=32240754|t=ä. Creating a Palliative Care Inpatient Response Plan for COVID-19?The UW Medicine Experience |pdf=|usr=}}
| |
| − | {{tp|p=32229286|t=ä. What Should Palliative Care s Response Be to the COVID-19 Pandemic?|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32278097|t=ä. The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32276099|t=ä. Rapid De-Escalation and Triaging Patients in Community-Based Palliative Care |pdf=|usr=}}
| |
| − | {{tp|p=32276097|t=ä. Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery |pdf=|usr=}}
| |
| − | {{tp|p=32276093|t=ä. Palliative Care in the time of COVID-19: Reflections from the frontline |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32317129|t=ä. The COVID-19 pandemic: Technology use to support the wellbeing of children |pdf=|usr=}}
| |
| − | {{tp|p=32359916|t=ä. From the editors: The COVID-19 crisis and its implications for pediatric surgeons |pdf=|usr=}}
| |
| − | {{tp|p=32278542|t=ä. (Ped.Surg.) Correspondence from Northern Italy about our experience with COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32328285|t=2020. Pharmacists at the frontline beating the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32312646|t=2020. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations |pdf=|usr=}}
| |
| − | {{tp|p=32291227|t=2020. Physiotherapists during COVID-19: usual business, in unusual times |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32368202|t=ä. Providing Steroid/Corticosteroid Injections Safely in the Covid-19 Environment |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32360375|t=ä. Forgetting ?routine? DVT and stroke during COVID-19 is a parallel pandemic that will be costly if ignored |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32360683|t=ä. COVID-19 financial resources for physicians |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32305585|t=ä. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32363343|t=2020. Infection prevention and control (IPC) for novel coronavirus (COVID-19) |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32342051|t=ä. Misdiagnosis in the COVID era: When Zebras are Everywhere, Don?t Forget the Horses |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32301962|t=ä. Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32313587|t=ä. Gestion de ... pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32342140|t=ä. Returning to orthopaedic business as usual after COVID-19: strategies and options |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32275309|t=ä. Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32119824|t=2020. The response of Milan s Emergency Medical System to the COVID-19 outbreak in Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32278369|t=2020. Palliative care and the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32240625|t=2020. Dementia care during COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32330432|t=ä. The implications of COVID-19 for the care of children living in residential institutions |pdf=|usr=}}
| |
| − | {{tp|p=32334646|t=ä. Practical recommendations for the management of diabetes in patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32289116|t=2020. COVID-19 and artificial intelligence: protecting health-care workers and curbing the spread |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32278364|t=ä. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines |pdf=|usr=}}
| |
| − | {{tp|p=32339472|t=ä. Diagnosing malaria and other febrile illnesses during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32334676|t=ä. Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32353270|t=2020. Public health messaging and harm reduction in the time of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32305078|t=ä. Blood transfusion strategies and ECMO during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32203711|t=ä. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32061335|t=2020. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32333858|t=ä. Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32312491|t=ä. Medication Shortages During the COVID-19 Crisis: What We Must Do |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32297490|t=2020. COVID-19 pandemic: what consequences for cardiac rehabilitation?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32355296|t=ä. Combating physical inactivity during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32339235|t=ä. A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32372821|t=2020. Crisis hits end-of-life care |pdf=|usr=}}
| |
| − | {{tp|p=32346357|t=ä. Kommentar: Gefahr der COVID-19-Ansteckung durch Medikamentenvernebelung |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32276799|t=2020. Nutrition support in the time of SARS-CoV-2 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32340020|t=2020. European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7155392|t=ä. Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO |pdf=|usr=}}
| |
| − | {{tp|p=32347519|t=ä. Letter to the Editor: Intragastric Balloon Removal During the COVID-19 Pandemic: to Postpone or Not? That Is the Question |pdf=|usr=}}
| |
| − | {{tp|p=32314249|t=ä. Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32304334|t=2020. Taking the Longer View of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32328297|t=2020. COVID-19 Pandemic: A New Chapter in the History of Infectious Diseases |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32360315|t=2020. COVID alias challenge to onco-rehabilitation and to viable indications and decisions: Cues from an Italian COVID+ oral cancer patient |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32348711|t=ä. Response and role of palliative care during the COVID-19 pandemic: A national telephone survey of hospices in Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32324727|t=2020. Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection - Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures and during autopsy practice |pdf=|usr=}}
| |
| − | {{tp|p=32292181|t=2020. Covid-19 current advice for pathologists |pdf=|usr=}}
| |
| − | {{tp|p=32324728|t=2020. What are the priorities of pathologists activities during COVID-19 emergency?|pdf=|usr=}}
| |
| − | {{tp|p=32324726|t=2020. Biosafety in surgical pathology in the era of SARS-Cov2 pandemia A statement of the Italian Society of Surgical Pathology and Cytology |pdf=|usr=}}
| |
| − | {{tp|p=32336348|t=2020. Effective health communication ? a key factor in fighting the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32153742|t=2020. 2019-nCoV: Polite with children!|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32302407|t=ä. Impact of COVID-19 on Physical Therapist Practice in Portugal |pdf=|usr=}}
| |
| − | {{tp|p=32302404|t=ä. The Essential Role of Home- and Community-Based Physical Therapists During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32280993|t=ä. Home and Community-Based Physical Therapist Management of Adults With Post?Intensive Care Syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32280973|t=ä. Italian Physical Therapists? Response to the Novel COVID-19 Emergency |pdf=|usr=}}
| |
| − | {{tp|p=32330124|t=2020. Leveraging open hardware to alleviate the burden of COVID-19 on global health systems |pdf=|usr=}}
| |
| − | {{tp|p=32312528|t=ä. Early reflection on the global impact of COVID19, and implications for physiotherapy |pdf=|usr=}}
| |
| − | {{tp|p=32323287|t=2020. Positionspapier zur praktischen Umsetzung der apparativen Differenzialtherapie der akuten respiratorischen Insuffizienz bei COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32294763|t=2020. Aufgaben der Weaning-Zentren im Pandemiefall COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32356639|t=2020. The ethical dimension of prioritization and allocation decisions within the context of the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32311049|t=ä. COVID-19 in Nursing Homes |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32249102|t=ä. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective |pdf=|usr=}}
| |
| − | {{tp|p=32247680|t=ä. Community pharmacists and communication in the time of COVID-19: Applying the health belief model |pdf=|usr=}}
| |
| − | {{tp|p=32224133|t=ä. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal |pdf=|usr=}}
| |
| − | {{tp|p=32317153|t=ä. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32278766|t=ä. Fighting against COVID-19: Innovative strategies for clinical pharmacists |pdf=|usr=}}
| |
| − | {{tp|p=32273253|t=ä. Hospital pharmacists? pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience |pdf=|usr=}}
| |
| − | {{tp|p=32362583|t=ä. Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward |pdf=|usr=}}
| |
| − | {{tp|p=32360181|t=ä. Pharmacists? readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles |pdf=|usr=}}
| |
| − | {{tp|p=32340892|t=ä. Media s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists |pdf=|usr=}}
| |
| − | {{tp|p=32340893|t=ä. Community pharmacists: On the frontline of health service against COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32317154|t=ä. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs |pdf=|usr=}}
| |
| − | {{tp|p=32307319|t=ä. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from LMICs |pdf=|usr=}}
| |
| − | {{tp|p=32081569|t=ä. Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32283116|t=2020. Collateral consequences of COVID-19 epidemic in Greater Paris |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32316737|t=2020. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32299184|t=2020. COVID-19 - where do we go from here?|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32283886|t=2020. Love in the time of coronavirus: training and service during COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32243846|t=2020. Message from the Editor: Stem Cell Science in the Time of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32208497|t=2020. COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes |pdf=|usr=}}
| |
| − | {{tp|p=32208494|t=2020. COVID-19: decision making and palliative care |pdf=|usr=}}
| |
| − | {{tp|p=32208495|t=2020. COVID-19 pandemic: triage for intensive-care treatment under resource scarcity |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32352150|t=2020. Age, comorbidity, frailty status: effects on disposition and resource allocation during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32336956|t=2020. Thrombosis management in times of COVID-19 epidemy; a Dutch perspective |pdf=|usr=}}
| |
| − | {{tp|p=32107119|t=ä. Coronavirus Disease 2019: Coronaviruses and Blood Safety |pdf=|usr=}}
| |
| − | {{tp|p=32147378|t=ä. COVID-19 and Blood Safety: Help with a Dilemma |pdf=|usr=}}
| |
| − | {{tp|p=32284222|t=2020. The active role of a blood center in outpacing the transfusion transmission of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32205269|t=ä. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32276778|t=ä. Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32272957|t=2020. COVID-19 the showdown for mass casualty preparedness and management: the Cassandra Syndrome |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32236694|t=ä. Geriatrie in Zeiten von Corona |pdf=|usr=}}
| |
| − | {{tp|p=32355606|t=ä. COVID-19 and digital epidemiology |pdf=|usr=}}
| |
| − | {{tp|p=32312362|t=2020. Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32377950|t=ä. Are we forgetting non-COVID-19-related diseases during lockdown?|pdf=|usr=}}
| |
| − | {{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32324618|t=2020. Prehabilitation (in case of stalled operations) May Help Mitigate an Increase in COVID-19 Peripandemic Surgical Morbidity and Mortality |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32380058|t=ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32253182|t=2020. Social distancing in covid-19: what are the mental health implications?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32330288|t=2020. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32259402|t=2020. Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32259387|t=2020. International perspectives: Impact of the COVID-19 pandemic on cytology |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32275124|t=2020. Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm |pdf=|usr=}}
| |
| − | {{tp|p=32358977|t=2020. New clinical needs and strategies for care in children with neurodisability during COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32259419|t=2020. Calculated decisions: COVID-19 calculators during extreme resource-limited situations |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32380475|t=2020. Endocrinology in the time of COVID-19: Management of Cushing s syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32369770|t=2020. Endocrinology in the time of COVID-19: Management of pituitary tumours |pdf=|usr=}}
| |
| − | {{tp|p=32380474|t=2020. Endocrinology in the time of COVID-19: Management of Hyponatraemia and Diabetes Insipidus |pdf=|usr=}}
| |
| − | {{tp|p=32379699|t=2020. Endocrinology in the time of COVID-19: Management of adrenal insufficiency |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32364597|t=2020. Ophthalmology After Coronavirus Disease 2019 (COVID-19): Transition Back to Patient Care |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32237972|t=2020. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies |pdf=|usr=}}
| |
| − | {{tp|p=32240543|t=ä. The impact of the SARS?CoV?2 outbreak on the safety and availability of blood transfusions in Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32198754|t=2020. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State |pdf=|usr=}}
| |
| − | {{tp|p=32280061|t=2020. COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?|pdf=|usr=}}
| |
| − | {{tp|p=32361996|t=2020. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission |pdf=|usr=}}
| |
| − | {{tp|p=32311760|t=2020. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment |pdf=|usr=}}
| |
| − | {{tp|p=32240537|t=2020. Post-donation COVID-19 identification in blood donors |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32268640|t=2020. Technical guideline for disinfection of wastewater and wastes of medical organizations during COVID-19 outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=C7186212|t=ä. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG? |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32412012|t=2020. Perspectives on the death investigation during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{ttp|p=32412013|t=2020. International Committee of the Red Cross (ICRC): General guidance for the management of the dead related to COVID-19 |pdf=|usr=}} ''no idea where to put it...''
| |
| − |
| |
| − |
| |
| − | {{tp|p=C7147918|t=2020. Caring for persons in detention suffering with mental illness during the Covid-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=C7144515|t=2020. Laboratory biosafety guide for 2019-nCoV (Second Edition) |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32386927|t=2020. Enfermedad por coronavirus 2019 (COVID-19) en Am�rica Latina: papel de la atenci�n primaria en la preparaci�n y respuesta |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32416989|t=ä. Failure modes and effect analysis to develop transfer protocols in the management of COVID-19 patients |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32381261|t=ä. Equality or utility? Ethics and law of rationing ventilators |pdf=|usr=}}
| |
| − | {{tp|p=32390668|t=2020. Social Work in the Time of the COVID-19 Pandemic: All in This Together?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32380228|t=ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Societies |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | üüpppü
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{ttp|p=32392488|t=2020. Transmission of coronavirus by nebulizer: a serious, underappreciated risk |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32253484|t=2020. Coronavirus disease 2019: Mehr Sicherheit durch kompakte Fakten und Handlungsempfehlungen |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32223773|t=ä. Ethical considerations in the allocation of critical care resources when capacity is overwhelmed |pdf=|usr=}}
| |
| − | {{tp|p=32234725|t=2020. Pandemic palliative care: beyond ventilators and saving lives |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{ttp|p=19412909|t=2009. Biosafety: Guidelines for Working with Pathogenic and Infectious Microorganisms |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32375855|t=2020. Ethics guidelines on COVID-19 triage?an emerging international consensus |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32413820|t=2020. Social isolation during Covid-19: Boon or bane to diabetes management |pdf=|usr=}}
| |
| − | {{tp|p=32388333|t=2020. Internet of things (IoT) applications to fight against COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32443202|t=2020. Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=C7128296|t=ä. Covid-19 et quelques probl�matiques �thiques en France |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32377324|t=2020. Epidemics and primary care in the UK |pdf=|usr=}}
| |
| − | {{tp|p=32387870|t=2020. Forensic medicine in the time of COVID 19: An Editorial from Milano, Italy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32295662|t=ä. Allocation of Scarce Resources in a Pandemic: A Systematic Review of US State Crisis Standards of Care Documents |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32257058|t=2020. Contributions and challenges of general practitioners in China fighting against the novel coronavirus crisis |pdf=|usr=}}
| |
| − | {{tp|p=32148740|t=2020. Challenges and responsibilities of family doctors in the new global coronavirus outbreak |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32287651|t=2020. Covid -19 in der Praxis |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32297850|t=ä. Pasteurized blood samples for transfusion compatibility testing during the coronavirus disease 2019 outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32292885|t=2020. COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals? |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32292635|t=2020. Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019? |pdf=|usr=}}
| |
| − | {{tp|p=32292634|t=2020. Holistic care for patients with severe coronavirus disease 2019: An expert consensus? |pdf=|usr=}}
| |
| − | {{tp|p=32388221|t=2020. Nursing s response to COVID-19: Lessons learned from SARS in Taiwan |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32387212|t=2020. Important considerations regarding the future management of coronavirus (COVID-19) |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32402799|t=ä. Early COVID-19 Impact on Adolescent Health and Medicine Programs in the United States: LEAH Program Leadership Reflections |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32380033|t=ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership |pdf=|usr=}}
| |
| − | {{tp|p=C7188123|t=ä. Contingency planning in the clinical laboratory: lessons learned amidst COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7184397|t=ä. A Laboratory Risk Assessment during the Coronavirus (COVID-19) Pandemic |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32376171|t=ä. After the COVID-19 Pandemic: Returning to Normalcy or Returning to a New Normal?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32408107|t=2020. Critical care capacity during the COVID-19 pandemic: Global availability of intensive care beds |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32452455|t=2020. Professional autonomy and liability of the resident doctor: Between the hammer and the anvil |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=C7151300|t=2020. Reflections on the quality of health care after the SARS-CoV-2 pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32386752|t=ä. Response of Chiropractic Organizations to the COVID-19 Pandemic: A Descriptive Report |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32268928|t=ä. Coronavirus epidemic and geriatric mental healthcare in China: how a coordinated response by professional organizations helped older adults during an unprecedented crisis |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32345529|t=2020. Extracorporeal Membrane Oxygenation ? Crucial Considerations during the Coronavirus Crisis |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32291724|t=ä. How Community and Unity Can Help Americans Survive |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32360084|t=2020. Nurses in Conflict: Providing Care in Extraordinary Times |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32387138|t=ä. COVID-19?Impact on DNR Orders in the Largest Cancer Center in Jordan |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32376263|t=ä. Palliative Care in the Time of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7141421|t=2020. Influence of Community and Culture in the Ethical Allocation of Scarce Medical Resources in a Pandemic Situation: Deliberative Democracy Study |pdf=|usr=}}
| |
| − | {{tp|p=32387113|t=ä. Caring for Pediatric Patients with Diabetes amidst the Coronavirus Disease 2019 Storm |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32386796|t=ä. Children are at risk from COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32448698|t=ä. Does nasal screening for Staphylococcus aureus before surgery compromise health care professional safety in the COVID-19 era?|pdf=|usr=}}
| |
| − | {{tp|p=32387163|t=ä. Commentary: When a cardiac surgeon takes care of patients with Coronavirus Disease 2019: It?s gonna be ok!|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32380086|t=ä. Caring for patients with venous insufficiency during the COVID-19 pandemic at a tertiary care center |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32458805|t=2020. Promoting healthy movement behaviours among children during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7200123|t=2020. COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way |pdf=|usr=}}
| |
| − | {{tp|p=C7194789|t=2020. Managing diabetes in Qatar during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32380008|t=ä. Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32389194|t=2020. Health system quality in the time of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=C7190296|t=2020. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study |pdf=|usr=}}
| |
| − | {{tp|p=C7201192|t=ä. Leadership, Management and Command in the time of the Coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=C7200366|t=2020. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception....|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32043976|t=2020. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32189286|t=2020. COVID-19 in der Allgemeinarztpraxis |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32304010|t=ä. Bariatric Surgery in the Times of Corona |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32405055|t=ä. Preparing for a responsible lockdown exit strategy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=C7155392|t=ä. Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32380453|t=2020. What dentists need to know about COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32381278|t=ä. Practical Bioethics during the Exceptional Circumstances of a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32387795|t=2020. COVID19 pandemic and people with opioid use disorder: innovation to reduce risk |pdf=|usr=}}
| |
| − | {{tp|p=32441268|t=ä. La rehabilitaci�n en los tiempos del COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32421541|t=2020. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32380028|t=2020. Drone delivery of AED s and personal protective equipment in the era of SARS-CoV-2 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32382213|t=2020. The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review |pdf=|usr=}}
| |
| − | {{tp|p=C7111621|t=ä. Science Education in the Era of a Pandemic: How Can History, Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32409154|t=2020. COVID-19: A perspective of a frontline worker |pdf=|usr=}}
| |
| − | {{tp|p=32417113|t=ä. A quick ?Can I donate blood? self-assessment tool amid the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32386966|t=ä. The blood supply management amid the COVID-19 outbreak |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32418663|t=ä. Cold Plasma, a New Hope in the Field of Virus Inactivation |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32342174|t=ä. Situation der Deutschen Universitätspathologien... |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32205158|t=2020. An integrated response to the impact of coronavirus outbreak on the Emergency Medical Services of Emilia Romagna |pdf=|usr=}}
| |
| − | {{tp|p=32334859|t=2020. La m�decine interne dans la pand�mie � SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32064701|t=2020. What should virologists be teaching their students?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32353114|t=ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32348044|t=2020. L'hematologie au temps du COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | ----
| |
